Xeljanz XR 11 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26FFF6E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,608
Award facts
- Contract value 100% obligated
- $27,608.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Xeljanz XR 11 mg tablets in quantities of 30s under a firm fixed-price contract with a ceiling value of $27,608.26. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of October 28, 2025. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which provides comprehensive pharmaceutical supply support valued at $999.99 million through December 2026.
AmerisourceBergen Drug Corp, as a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's federal contract portfolio encompasses a diverse range of pharmaceutical products and medical supplies across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. As a prime contractor for DLA's Medical Supply Chain, AmerisourceBergen maintains the capacity to fulfill federal medical supply needs through open competition, supporting customers including the Defense Health Agency and U.S. Coast Guard through flexible contract vehicles designed to ensure reliable pharmaceutical availability for military healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FFF6E?
SPE2DR26FFF6E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DR26FFF6E worth?
The government has obligated $27,608 on SPE2DR26FFF6E.
Is contract SPE2DR26FFF6E an order under another contract?
Yes. SPE2DR26FFF6E is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFF6E competed?
The extent of competition for SPE2DR26FFF6E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award